Navigation Links
Combination of Bronchoscopic Techniques is Very Effective for Lung Lesions

A new study shows that the combined use of two minimally invasive techniquesendobronchial ultrasound (EBUS) and electromagnetic navigation bronchoscopy (ENB)-- in the diagnosis of peripheral lung lesions has been shown to be more effective than either procedure alone and does not compromise patients safety.

Multimodality diagnosis with the joint use of EBUS with ENB has pushed the diagnostic yield of flexible bronchoscopic procedures closer to the sensitivity obtainable through either transthoracic CT-guided or surgical biopsies, noted Armin Ernst, M.D., of Harvard Medical School, who wrote the article with colleagues at the University of Heidelberg, Germany.

The ultimate goal of reliable and minimally invasive biopsy of peripheral lung lesions new appears feasible.

The results of the prospective, randomized and multicenter trial were reported in the first issue for July 2007 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.

The study recruited 120 patients with evidence of peripheral lung lesions or solitary pulmonary lesions on prior CT scans who were randomly assigned to undergo bronchoscopic diagnosis by one of three techniques: EBUS alone, ENB alone, or ENB and EBUS in combination.

The diagnostic yieldthe percentage of correct diagnosesof each was then analyzed. If these minimally invasive techniques proved inconclusive, a surgical biopsy, the gold-standard for diagnosis, was performed.

The design of the study deserves comment and compliment, wrote Gerard Silvestri, M.D., M.S., in an accompanying editorial. Rarely do we see a prospective, multicenter trial in the field of interventional pulmonology. Rarer still are subjects randomized to different treatment strategies.

EBUS and ENB represent newer technologies that are growing in use. EBUS allows for direct visualization of lesions, but lacks a navigati on system and requires the operator to maneuver based on prior radiological investigations, such as CT scans. ENB, on the other hand, has a highly specialized real-time navigation system, but lacks a means of directly visualizing the lesion.

The researchers found that the EBUS procedure by itself had a diagnostic yield of 69 percent. ENB alone had a diagnostic yield of 59 percent. But the combination of the two increased the diagnostic yield to 88 percent, independent of lesion sizea highly significant improvement.

In addition, the researchers noted a trend toward improved sensitivity in detecting benign diseases, though it was not statistically significant.

The safety of the combined procedures was assessed by tracking of complications. One of the primary negative outcomes in bronchoscopy is pneumothorax. In this study, the rate of pneumothorax using either ENB or EBUS alone was 5 percent, and in the combined procedures it was 8 percenta statistically insignificant difference.

Another concern was that the extended sedation or anesthesia required in the combined procedure may increase adverse effects due to prolonged sedation or anesthesia, but none was documented.

In his editorial, Dr. Silvestri notes that this study would most likely benefit patients who were too sick to undergo a surgical biopsy but would benefit from chemotherapy if cancer was confirmed through this combined, minimally invasive technique.


'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... , ... October 12, 2017 , ... On Saturday, October ... treadmill relay – Miles by Moonlight to raise money for the American Heart Association ... more. , Teams will work together to keep their treadmills moving for 5 ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... ORLANDO, Fla. , Oct. 2, 2017  AllianceRx ... services company formed by Walgreens and pharmacy benefit manager ... of its new brand, which included the unveiling of ... Fla. , as well as at a few ... introduces the new brand to patients, some of whom ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: